Plavix Charges Settled, But More May Be Coming

Law360 (May 11, 2007, 12:00 AM EDT) -- Now that Bristol-Myers Squibb Co. has tentatively settled criminal antitrust charges with the U.S. Department of Justice, it will wait to see whether the Federal Trade Commission or states take civil action against it over a failed Plavix patent agreement.

Bristol-Myers Squibb announced Thursday that it would plead guilty to two counts of making false statements to the government and pay a fine of up to $1 million. In return, the DOJ will not pursue more serious criminal charges against it.

“Full compliance with all of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.